These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29281988)

  • 1. Intravenous artesunate plus Artemisnin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial.
    Byakika-Kibwika P; Achan J; Lamorde M; Karera-Gonahasa C; Kiragga AN; Mayanja-Kizza H; Kiwanuka N; Nsobya S; Talisuna AO; Merry C
    BMC Infect Dis; 2017 Dec; 17(1):794. PubMed ID: 29281988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial.
    Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN
    Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
    Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
    Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of oral artesunate and quinine plus tetracycline in acute uncomplicated falciparum malaria.
    Karbwang J; Na-Bangchang K; Thanavibul A; Bunnag D; Chongsuphajaisiddhi T; Harinasuta T
    Bull World Health Organ; 1994; 72(2):233-8. PubMed ID: 8205643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
    Dondorp AM; Fanello CI; Hendriksen IC; Gomes E; Seni A; Chhaganlal KD; Bojang K; Olaosebikan R; Anunobi N; Maitland K; Kivaya E; Agbenyega T; Nguah SB; Evans J; Gesase S; Kahabuka C; Mtove G; Nadjm B; Deen J; Mwanga-Amumpaire J; Nansumba M; Karema C; Umulisa N; Uwimana A; Mokuolu OA; Adedoyin OT; Johnson WB; Tshefu AK; Onyamboko MA; Sakulthaew T; Ngum WP; Silamut K; Stepniewska K; Woodrow CJ; Bethell D; Wills B; Oneko M; Peto TE; von Seidlein L; Day NP; White NJ;
    Lancet; 2010 Nov; 376(9753):1647-57. PubMed ID: 21062666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand.
    Noedl H; Krudsood S; Chalermratana K; Silachamroon U; Leowattana W; Tangpukdee N; Looareesuwan S; Miller RS; Fukuda M; Jongsakul K; Sriwichai S; Rowan J; Bhattacharyya H; Ohrt C; Knirsch C
    Clin Infect Dis; 2006 Nov; 43(10):1264-71. PubMed ID: 17051490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous artesunate plus oral dihydroartemisinin-piperaquine or intravenous quinine plus oral quinine for optimum treatment of severe malaria: lesson learnt from a field hospital in Timika, Papua, Indonesia.
    Sikora SA; Poespoprodjo JR; Kenangalem E; Lampah DA; Sugiarto P; Laksono IS; Ahmad RA; Murhandarwati EEH
    Malar J; 2019 Dec; 18(1):448. PubMed ID: 31888655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artesunate versus quinine for treating severe malaria.
    Jones KL; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005967. PubMed ID: 17943870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial.
    Dorsey G; Staedke S; Clark TD; Njama-Meya D; Nzarubara B; Maiteki-Sebuguzi C; Dokomajilar C; Kamya MR; Rosenthal PJ
    JAMA; 2007 May; 297(20):2210-9. PubMed ID: 17519410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
    Yeka A; Banek K; Bakyaita N; Staedke SG; Kamya MR; Talisuna A; Kironde F; Nsobya SL; Kilian A; Slater M; Reingold A; Rosenthal PJ; Wabwire-Mangen F; Dorsey G
    PLoS Med; 2005 Jul; 2(7):e190. PubMed ID: 16033307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of the efficacy of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital, Cameroon.
    Maka DE; Chiabi A; Ndikum V; Achu D; Mah E; Nguefack S; Nana P; Njoumemi Z; Mbacham W; Mbonda E
    Malar J; 2015 Oct; 14():429. PubMed ID: 26520401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artemisinin derivatives versus quinine in treating severe malaria in children: a systematic review.
    Praygod G; de Frey A; Eisenhut M
    Malar J; 2008 Oct; 7():210. PubMed ID: 18928535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of artemisinin suppositories, intramuscular artesunate and intravenous quinine for the treatment of severe childhood malaria.
    Cao XT; Bethell DB; Pham TP; Ta TT; Tran TN; Nguyen TT; Pham TT; Nguyen TT; Day NP; White NJ
    Trans R Soc Trop Med Hyg; 1997; 91(3):335-42. PubMed ID: 9231212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artesunate versus quinine for treating severe malaria.
    Sinclair D; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2011 Mar; (3):CD005967. PubMed ID: 21412892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.